{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:02:15Z","timestamp":1791925335960,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11739-020-02434-9","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T19:02:36Z","timestamp":1594407756000},"page":"167-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4628-4825","authenticated-orcid":false,"given":"Giacomo","family":"Marchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4642-0230","authenticated-orcid":false,"given":"Fabiana","family":"Busti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Vianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-1899","authenticated-orcid":false,"given":"Domenico","family":"Girelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"issue":"5","key":"2434_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","volume":"1","author":"JGF Cleland","year":"2016","unstructured":"Cleland JGF, Zhang J, Pellicori P, Dicken B, Dierckx R, Shoaib A et al (2016) Prevalence and outcomes of anemia and hematinic dificiencies in patients with chronic heart failure. JAMA Cardiol 1(5):539\u2013547. https:\/\/doi.org\/10.1001\/jamacardio.2016.1161","journal-title":"JAMA Cardiol"},{"issue":"9","key":"2434_CR2","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.amjcard.2016.02.018","volume":"117","author":"TJ Cooper","year":"2016","unstructured":"Cooper TJ, Anker SD, Comin-Colet J, Filippatos G, Lainscak M, Luscher TF et al (2016) Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia. Am J Cardiol 117(9):1482\u20131487. https:\/\/doi.org\/10.1016\/j.amjcard.2016.02.018","journal-title":"Am J Cardiol"},{"key":"2434_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","volume":"58","author":"DO Okonko","year":"2011","unstructured":"Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA (2011) Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 58:1241\u20131251. https:\/\/doi.org\/10.1016\/j.jacc.2011.04.040","journal-title":"J Am Coll Cardiol"},{"key":"2434_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ehf2.12485","volume":"6","author":"C Jacob","year":"2019","unstructured":"Jacob C, Altevers J, Barck I, Hardt T, Braun T, Greiner W (2019) Retrospective analysis into differences in heart failure patients with and without iron deficiency or anaemia. ESC Heart Failure 6:840\u2013855. https:\/\/doi.org\/10.1002\/ehf2.12485","journal-title":"ESC Heart Failure"},{"key":"2434_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11739-019-02024-4","volume":"15","author":"A Belfiore","year":"2020","unstructured":"Belfiore A, Palmieri VO, Di Gennaro C, Settimo E, De Sario MG, Lattanzio S et al (2020) Long-term management of chronic heart failure patients in internal medicine. Int Emerg Med 15:49\u201358. https:\/\/doi.org\/10.1007\/s11739-019-02024-4","journal-title":"Int Emerg Med"},{"key":"2434_CR6","doi-asserted-by":"publisher","unstructured":"Anand I, Gupta P (2020) How I treat anemia in heart failure. Blood, 2020 Jan 2;blood.2019004004. https:\/\/doi.org\/10.1182\/blood.2019004004","DOI":"10.1182\/blood.2019004004"},{"key":"2434_CR7","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin-Colet J, Filippatos G, Willenheimer R, Diskstein K, Drexler H et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436\u20132448. https:\/\/doi.org\/10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"issue":"27","key":"2434_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"issue":"15","key":"2434_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","volume":"136","author":"DJ Van Veldhuisen","year":"2017","unstructured":"Van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, Bohm M, Doletsky A et al (2017) Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation 136(15):1374\u20131383. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.027497","journal-title":"Circulation"},{"issue":"7","key":"2434_CR10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","volume":"71","author":"BML Rocha","year":"2018","unstructured":"Rocha BML, Cunha GJL, Menezes Falcao LF (2018) The burden of iron deficiency in heart failure: therapeutic approach. J Am Coll Cardiol 71(7):782\u2013793. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.027","journal-title":"J Am Coll Cardiol"},{"key":"2434_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11739-018-1820-3","volume":"13","author":"KL Londono","year":"2018","unstructured":"Londono KL, Formiga F, Chivite D, Moreno-Gonzales R, Migone De Amicis M, Corbella X (2018) Prognostic influence of prior chronic obstructive pulmonary disease in patients admitted for their first episode of acute heart failure. Intern Emerg Med 13:351\u2013357. https:\/\/doi.org\/10.1007\/s11739-018-1820-3","journal-title":"Intern Emerg Med"},{"key":"2434_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s11739-018-1941-8","volume":"13","author":"PM Mannucci","year":"2019","unstructured":"Mannucci PM, Nobili A, Pasina L et al (2019) Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register. Intern Emerg Med 13:1191\u20131200. https:\/\/doi.org\/10.1007\/s11739-018-1941-8","journal-title":"Intern Emerg Med"},{"issue":"1","key":"2434_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","volume":"138","author":"IS Anand","year":"2018","unstructured":"Anand IS, Gupta P (2018) Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation 138(1):80\u201398. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.030099","journal-title":"Circulation"},{"issue":"4","key":"2434_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Raza Shaikh S et al (2017) Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nature Rev Cardiol 14(4):238\u2013250. https:\/\/doi.org\/10.1038\/nrcardio.2016.203","journal-title":"Nature Rev Cardiol"},{"key":"2434_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ehf2.12490","volume":"6","author":"C Adlbrecht","year":"2019","unstructured":"Adlbrecht C (2019) Intravenous iron therapy for patients with heart failure: expanding body of evidence. ESC Heart Fail 6:581\u2013583. https:\/\/doi.org\/10.1002\/ehf2.12490","journal-title":"ESC Heart Fail"},{"key":"2434_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ejhf.229","volume":"17","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, Filippatos G, Comin-Colet J, Willenheimer R, Dickstein K, L\u00fcscher T et al (2015) The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. Eur J Heart Fail 17:329\u2013339. https:\/\/doi.org\/10.1002\/ejhf.229","journal-title":"Eur J Heart Fail"},{"key":"2434_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1492","author":"O Chioncel","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C et al (2019) Acute heart failure congestion and perfusion status \u2013 impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.1492","journal-title":"Eur J Heart Fail"},{"key":"2434_CR18","doi-asserted-by":"publisher","first-page":"9371967","DOI":"10.1155\/2020\/9371967","volume":"2020","author":"P Krzesinski","year":"2020","unstructured":"Krzesinski P, Galas A, Gielerak G, Uzi\u0119b\u0142o-\u017byczkowska B (2020) Haemodynamic Effects of Anaemia in Patients with Acute Decompensated Heart Failure. Card Res Pract 2020:9371967. https:\/\/doi.org\/10.1155\/2020\/9371967","journal-title":"Card Res Pract"},{"key":"2434_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ehf2.12462","volume":"6","author":"DO Okonko","year":"2019","unstructured":"Okonko DO, Jouhra F, Abu-Own H, Filippatos G, Colet JC, Suki C et al (2019) Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR-HF substudy. ESC Heart Fail 6:621\u2013628. https:\/\/doi.org\/10.1002\/ehf2.12462","journal-title":"ESC Heart Fail"},{"key":"2434_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11739-018-1958-z","volume":"14","author":"R Melchio","year":"2019","unstructured":"Melchio R, Rinaldi G, Testa E, Giraudo A, Serraino C, Bracco C et al (2019) Red cell distribution width predicts mid-term prognosis in patients hospitalized with acute heart failure: the RDW in Acute Heart Failure (RE-AHF) study. Intern Emerg Med 14:239\u2013247. https:\/\/doi.org\/10.1007\/s11739-018-1958-z","journal-title":"Intern Emerg Med"},{"key":"2434_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-020-02343-x","author":"SD Ye","year":"2020","unstructured":"Ye SD, Wang SJ, Wang GG, Li L, Huang ZW, Qin J et al (2020) Association between anemia and outcome in patients hospitalized for acute heart failure syndromes: findings from Beijing Acute Heart Failure Registry (Beijing AHF Registry). Intern Emerg Med. https:\/\/doi.org\/10.1007\/s11739-020-02343-x","journal-title":"Intern Emerg Med"},{"issue":"6","key":"2434_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11739-017-1637-5","volume":"12","author":"M Migone de Amicis","year":"2017","unstructured":"Migone de Amicis M, Chivite D, Corbella X, Cappellini MD, Formiga F (2017) Anemia is a mortality prognostic factor in patients initially hospitalized for acute heart failure. Intern Emerg Med 12(6):749\u2013756. https:\/\/doi.org\/10.1007\/s11739-017-1637-5","journal-title":"Intern Emerg Med"},{"issue":"3","key":"2434_CR23","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2214-109X(20)30004-8","volume":"8","author":"J Tromp","year":"2020","unstructured":"Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W et al (2020) Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Health 8(3):e411\u2013e422. https:\/\/doi.org\/10.1016\/S2214-109X(20)30004-8","journal-title":"Lancet Glob Health"},{"key":"2434_CR24","doi-asserted-by":"publisher","unstructured":"Llauger L, Jacob J, Herrero.Puente P, Aguirre A, Su\u00f1\u00e9n-Cuquerella G, Corominas-Lasalle G, et al (2020) The CRAS-EAHFE study: characteristics and prognosis of acute heart failure episodes with cardiorenal-anemia syndrome at the emergency department. Eur Heart J: Acute Cardiovascular Care.https:\/\/doi.org\/10.1177\/2048872620921602","DOI":"10.1177\/2048872620921602"},{"key":"2434_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1795","author":"AS Bhatt","year":"2020","unstructured":"Bhatt AS, Ambrosy AP, Dunning A, DeVore AD, Butler J, Reed S et al (2020) The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial \u2013 insights from ASCEND-HF. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.1795","journal-title":"Eur J Heart Fail"},{"key":"2434_CR26","doi-asserted-by":"publisher","first-page":"e001153","DOI":"10.1136\/openhrt-2019-001153","volume":"7","author":"JM Beattie","year":"2020","unstructured":"Beattie JM, Khatib R, Phillips CJ, Williams SG (2020) Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study. Open Heart 7:e001153. https:\/\/doi.org\/10.1136\/openhrt-2019-001153","journal-title":"Open Heart"},{"key":"2434_CR27","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM et al (2017) 2017 ACC\/ AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the Management of Heart Failure: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Circulation 136:e137\u2013e161. https:\/\/doi.org\/10.1161\/CIR.0000000000000509","journal-title":"Circulation"},{"issue":"6\u20137","key":"2434_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.acvd.2019.02.002","volume":"112","author":"L Sportouch","year":"2019","unstructured":"Sportouch L, Cautela J, Resseguier N, Pinto J, Ammar C, Gaubert M et al (2019) Dynamic iron status after acute heart failure. Arch Cardiovasc Dis 112(6\u20137):410\u2013419. https:\/\/doi.org\/10.1016\/j.acvd.2019.02.002","journal-title":"Arch Cardiovasc Dis"},{"key":"2434_CR29","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/ejhf.837","volume":"19","author":"LNL Van Aelst","year":"2017","unstructured":"Van Aelst LNL, Abraham M, Sadoune M, Lefebvre T, Manivet P, Logeart D et al (2017) Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: Early in-hospital phase and 30-day follow-up. Eur J Heart Fail 19:1075\u20131076. https:\/\/doi.org\/10.1002\/ejhf.837","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"2434_CR30","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","volume":"35","author":"EA Jankowska","year":"2014","unstructured":"Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Ole\u015bkowska-Florek W et al (2014) Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 35(36):2468\u20132476. https:\/\/doi.org\/10.1093\/eurheartj\/ehu235","journal-title":"Eur Heart J"},{"key":"2434_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100861","author":"C Camaschella","year":"2020","unstructured":"Camaschella C, Girelli D (2020) The changing landscape of iron deficiency. Mol Asp Med. https:\/\/doi.org\/10.1016\/j.mam.2020.100861","journal-title":"Mol Asp Med"},{"issue":"23","key":"2434_CR32","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1182\/blood-2015-12-639112","volume":"127","author":"D Girelli","year":"2016","unstructured":"Girelli D, Nemeth E, Swinkels DW (2016) Hepcidin in the diagnosis of iron disorders. Blood 127(23):2809\u20132813. https:\/\/doi.org\/10.1182\/blood-2015-12-639112","journal-title":"Blood"},{"key":"2434_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ehf2.12250","volume":"5","author":"TJ Yeo","year":"2018","unstructured":"Yeo TJ, Yeo PSD, Hadi FA, Cushway T, Lee KY, Yin FF et al (2018) Single-dose intravenous iron in southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC Heart Fail 5:344\u2013353. https:\/\/doi.org\/10.1002\/ehf2.12250","journal-title":"ESC Heart Fail"},{"issue":"1","key":"2434_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12185-017-2373-3","volume":"107","author":"D Girelli","year":"2018","unstructured":"Girelli D, Ugolini S, Busti F, Marchi G, Castagna A (2018) Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol 107(1):16\u201330. https:\/\/doi.org\/10.1007\/s12185-017-2373-3","journal-title":"Int J Hematol"},{"issue":"4","key":"2434_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11739-019-02223-z","volume":"15","author":"I Motta","year":"2019","unstructured":"Motta I, Mantovan G, Consonni D, Brambilla AM, Materia M, Porzio M et al (2019) Treatment with ferric carboxymaltose in stable patients with severe iron deficiency anemia in the emergency department. Intern Emerg Med 15(4):629\u2013634. https:\/\/doi.org\/10.1007\/s11739-019-02223-z","journal-title":"Intern Emerg Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02434-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-020-02434-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02434-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:26:15Z","timestamp":1625876775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-020-02434-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2434"],"URL":"https:\/\/doi.org\/10.1007\/s11739-020-02434-9","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"GM, FB and AV have no potential conflict of interest. DG has been member of La Jolla Pharmaceuticals, Silence Therapeutics and Novartis Advisory Boards, and has received fees for lectures from Vifor Pharma and Sanofi-Genzyme.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any study with human and animals by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements on human and animal rights"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}